SCHEMBL18326014

SCHEMBL18326014

c1ccc(C2(c3ccc(N(c4ccc(-c5ccc6oc7ccccc7c6c5)cc4)c4ccc(-c5cccc6ccccc56)cc4)cc3)c3ccccc3-c3ccccc32)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 2/20 0.34
CA1 P00915 2/20 0.34
CA2 P00918 2/20 0.34
CA9 Q16790 2/20 0.34
PLA2G2A P14555 2/20 0.33
PLA2G4A P47712 2/20 0.33
HSP90AA1 P07900 1/20 0.32
HSP90AB1 P08238 1/20 0.32
PLA2G10 O15496 1/20 0.32
KMT2A Q03164 3/20 0.32
KDM4E B2RXH2 3/20 0.32
MAPT P10636 3/20 0.32
MEN1 O00255 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
LMNA P02545 1/20 0.32
OPRK1 P41145 1/20 0.32
CHRNB4 P30926 2/20 0.31
CHRNA3 P32297 2/20 0.31
CHRNA1 P02708 1/20 0.31
CHRNG P07510 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16996008 0.95 CA12 (0.33) CA12CA1CA2CA9PLA2G2A
SCHEMBL18326164 0.94 CA12 (0.34) CA12CA1CA2CA9KMT2A
SCHEMBL23770223 0.93 CA12 (0.33) CA12CA1CA2CA9PLA2G2A
SCHEMBL16631101 0.93 MAPT (0.32) CA12CA1CA2CA9HSP90AA1
SCHEMBL17805070 0.93 PLA2G2A (0.37) PLA2G2APLA2G4AHSP90AA1HSP90AB1PLA2G10
SCHEMBL17804694 0.93 PLA2G2A (0.37) PLA2G2APLA2G4AHSP90AA1HSP90AB1PLA2G10
SCHEMBL23239414 0.92 PLA2G2A (0.34) CA12CA1CA2CA9PLA2G2A
SCHEMBL17804702 0.92 PLA2G2A (0.39) PLA2G2APLA2G4AHSP90AA1HSP90AB1PLA2G10
SCHEMBL17804958 0.92 PLA2G2A (0.39) PLA2G2APLA2G4AHSP90AA1HSP90AB1PLA2G10
SCHEMBL17805056 0.92 PLA2G2A (0.39) PLA2G2APLA2G4AHSP90AA1HSP90AB1PLA2G10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11563179-B2 Compound, organic optoelectronic element comprising same and display device thereof SAMSUNG SDI CO., LTD. (KR) 2023-01-24 US disclosed
US-20160372666-A1 COMPOUND, ORGANIC OPTOELECTRONIC ELEMENT COMPRISING SAME AND DISPLAY DEVICE THEREOF SAMSUNG SDI CO., LTD. (KR) 2016-12-22 US disclosed
US-20160372666-A1 COMPOUND, ORGANIC OPTOELECTRONIC ELEMENT COMPRISING SAME AND DISPLAY DEVICE THEREOF SAMSUNG SDI CO., LTD. (KR) 2016-12-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160372666-A1 COMPOUND, ORGANIC OPTOELECTRONIC ELEMENT COMPRISING SAME AND DISPLAY DEVICE THEREOF OR10J3, OR51E2, ORMDL3 CA12 338/4885CA1 673/4885CA2 1050/4885
US-11563179-B2 Compound, organic optoelectronic element comprising same and display device thereof OR10J3, OR51E2, ORMDL3 CA12 338/4885CA1 673/4885CA2 1050/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.